Vera Putter
Berlin, BE 13353, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
KAT6A-inhibitor co-crystal structures: tackling a challenging crystallization target via two alternative approaches.
Journal: Acta crystallographica. Section D, Structural biology
Published: August 27, 2026
Identification of the Piperidyl Urea Derivative BAY-439 as a Potent and Selective Inhibitor of Human Phospholipase A2 Group V (hPLA2-G5) for the Treatment of Inflammatory Pain.
Journal: Journal of medicinal chemistry
Published: May 19, 2026
CACHE Challenge #3: Targeting the Nsp3 Macrodomain of SARS-CoV-2.
Journal: Journal of chemical information and modeling
Published: January 21, 2026
CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13.
Journal: Journal of chemical information and modeling
Published: June 20, 2025
CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson's Disease Associated Protein.
Journal: Journal of chemical information and modeling
Published: November 05, 2024
Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran In Vivo-Active KAT6AB Inhibitor.
Journal: Journal of medicinal chemistry
Published: October 25, 2024
Identification of NUV-244 as a PNPLA3 I148M degrading small molecule.
Journal: iScience
Published: September 03, 2024
Surface-mutagenesis strategies to enable structural biology crystallization platforms.
Journal: Acta crystallographica. Section D, Structural biology
Published: May 09, 2024
Transport and inhibition of the sphingosine-1-phosphate exporter SPNS2.
Journal: Nature communications
Published: April 02, 2024
Protein Binder Toolbox for Studies of Solute Carrier Transporters.
Journal: Journal of molecular biology
Published: March 05, 2024
High-Throughput Expression and Purification of Human Solute Carriers for Structural and Biochemical Studies.
Journal: Journal of visualized experiments : JoVE
Published: October 16, 2023
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis.
Journal: Molecular oncology
Published: August 08, 2023
Last Updated: 09/26/2026